Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copper

Nuclear Medicine and Biology

Volumn 31, Issue 6, 2004, Pages 795-802

  Brady, Erik D ^a   Chong, Hyun Soon ^a   Milenic, Diane E ^a   Brechbiel, Martin W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Arsenazo III; Copper 64; Ligand to protein ratio; Monoclonal antibodies; Radioimmunotherapy; UV Vis spectroscopy

Indexed keywords

2 (4 ISOTHIOCYANATOBENZYL) 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; 2 (4 ISOTHIOCYANATOBENZYL) 1,4,8,11 TETRAAZACYCLOTETRADECANE N,N',N'',N''' TETRAACETIC ACID; ARSENAZO 3; COPPER COMPLEX; LIGAND; MACROCYCLIC COMPOUND; MONOCLONAL ANTIBODY; PROTEIN; PYRIDINE DERIVATIVE; TACHPYRIDINE; TRASTUZUMAB; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; ISOTOPE LABELING; TITRIMETRY; ULTRAVIOLET SPECTROSCOPY;

ANTIBODIES, MONOCLONAL; CHROMATOGRAPHY, THIN LAYER; COPPER; COPPER RADIOISOTOPES; CYCLOHEXYLAMINES; INDICATORS AND REAGENTS; LIGANDS; MALEIMIDES; PROTEINS; RADIOPHARMACEUTICALS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 3042707742     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2004.04.004     Document Type: Article

References (37)

1. Milenic D.E. Monoclonal Antibody-Based Therapy Strategies Providing options for the cancer patient. Curr Pharm Design. 8:2002;1749-1764
2. Meyer D.L., Senter P.D. Recent Advances in Antibody Drug Conjugates for Cancer Therapy. Annu Rep Med Chem. 38:2003;229-237
3. Trikha M., Corringham R., Klein B., Rossi J.F. Targeted Anti-Interleukin-6 Monoclonal Antibody Therapy for Cancer A Review of the Rationale and Clinical Evidence. Clin Cancer Res. 9:2003;4653-4665
4. Pedley R.B. Pharmacokinetics of Monoclonal Antibodies - Implications for their use in Cancer Therapy. Clin Immunother. 6:1996;54-67
5. Volkert W.A., Hoffman T.J. Therapeutic Radiopharmaceuticals. Chem Rev. 99:1999;2269-2292
6. Liu S., Edwards D.S. Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals. Bioconjugate Chem. 12:2001;7-34
7. Schubiger P.A., Alberto R., Smith A. Vehicles, Chelators, and Radionuclides Choosing the "Building Blocks" of an Effective Therapeutic Radioimmunoconjugate. Bioconjugate Chem. 7:1996;165-179
8. Meares C.F., McCall M.J., Deshpande S.V., DeNardo S.J., Goodwin D.A. Chelate Radiochemistry Cleavable Linkers Lead to Altered Levels of Radioactivity in the Liver. Int J Cancer Suppl. 2:1988;99-102
9. Chi D.Y., O'Neil J.P., Anderson C.J., Welch M.J., Katzenellenbogen J.A. Homodimeric and Heterodimeric Bis(amino thiol) Oxometal Complexes with Rhenium(V) and Technetium(V). Control of Heterodimeric Complex Formation and an Approach to Metal Complexes that Mimic Steroid Hormones. J Med Chem. 37:1994;928-937
10. Pippin C.G., Parker T.A., McMurry T.J., Brechbiel M.W. Spectrophotometric Method for the Determination of a Bifunctional DTPA Ligand in DTPA-Monoclonal Antibody Conjugates. Bioconjugate Chem. 3:1992;342-354
11. Dadachova E., Chappell L.L., Brechbiel M.W. Spectrophotometric Method for Determination of Bifunctional Macrocyclic Ligands in Macrocyclic Ligand-Protein Conjugates. Nucl Med Biol. 26:1999;977-982
12. Brechbiel M.W., Gansow O.A., Atcher R.W., Schlom J., Esteban J., Simpson D.E., Colcher D. Synthesis of 1-(p-Isothiocyanatobenzyl) Derivatives of DTPA and EDTA - Antibody Labeling and Tumor-Imaging Studies. Inorg Chem. 25:1986;2772-2781
13. Mathias C.J., Sun Y., Connett J.M., Philpott G.W., Welch M.J., Martell A.E. A new bifunctional chelate, N-(2-hydroxy-3, 5-dimethylbenzyl)-N'-(2- hydroxy-5-(bromoacetamido)benzyl)ethylenediamine-N, N'-diacetic acid (BrMe2HBED) an effective conjugate for radiometals and antibodies. Inorg Chem. 29:1990;1475-1480
14. Paik C.H., Murphy P.R., Eckelman W.C., Volkert W.A., Reba R.C. Optimization of the DTPA Mixed-Anhydride Reaction with Antibodies at Low Concentration. J Nucl Med. 24:1983;932-936
15. Lewis M.R., Raubitschek A., Shively J.E. A Facile, Water-Soluble Method for Modification of Proteins with DOTA. Use of Elevated Temperature and Optimized pH To Achieve High Specific Activity and High Chelate Stability in Radiolabeled Immunoconjugates. Bioconjugate Chem. 5:1994;565-576
16. Meares C.F., McCall M.J., Reardan D.T., Goodwin D.A., Diamanti C.I., McTigue M. Conjugation of Antibodies with Bifunctional Chelating Agents Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Anal Biochem. 142:1984;68-78
17. Lewis M.R., Kao J.Y., Anderson A.L., Shively J.E., Raubitschek A. An Improved Method for Conjugating Monoclonal Antibodies with N- Hydroxysulfosuccinimidyl DOTA. Bioconjugate Chem. 12:2001;320-324
18. Brandt K.D., Schnobrich K.E., Johnson D.K. Characterization of Antibody-Chelator Conjugates - Determination of Chelator Content by Terbium Fluorescence Titration. Bioconjugate Chem. 2:1991;67-70
19. 203Pb labeled monoclonal antibodies. Inorg Chim Acta. 239:1995;43-51
20. Delgado R., Frausto da Silva J.J.R., Vaz M.C.T.A. Copper(II) Complexes of Cyclic Tetraazatetraacetic Acids - Unusual Features and Possible Analytical Applications. Talanta. 33:1986;285-287
21. Delgado R., Sun Y., Motekaitis R.J., Martell A.E. Stabilities of Divalent and Trivalent Metal Ion Complexes of Macrocyclic Triazatriacetic Acids. Inorg Chem. 32:1993;3320-3326
22. Blower P.J., Lewis J.S., Zweit J. Copper Radionuclides and Radiopharmaceuticals in Nuclear Medicine. Nucl Med Biol. 23:1996;957-980
23. Novak-Hofer I., Schubiger P.A. Copper-67 as a therapeutic nuclide for radioimmunotherapy. Eur J Nucl Med Mol Imaging. 29:2002;821-830
24. 67Cu-2IT-BAT-Lym-1 Pharmacokinetics, Radiation Dosimetry, Toxicity and Tumor Regression in Patients with Lymphoma. J Nucl Med. 40:1999;302-310
25. Smith-Jones P.M., Fridrich R., Kaden T.A., Novak-Hofer I., Siebold K., Tschudin D., Maecke H.R. Antibody Labeling with Copper-67 Using the Bifunctional Macrocycle 4-[(1, 4, 8, 11-Tetraazacyclotetradec-1-yl)methyl]benzoic Acid. Bioconjugate Chem. 2:1991;415-421
26. Studer M., Meares C.F. Synthesis of Novel 1, 4, 7-Triazacyclononane-N, N′, N′′-triacetic Acid Derivatives Suitable for Protein Labeling. Bioconjugate Chem. 3:1992;337-341
27. McMurry T.J., Brechbiel M., Wu C., Gansow O.A. Synthesis of 2-(p-Thiocyanatobenzyl)-1, 4, 7-triazacyclononane-1, 4, 7-triacetic Acid Application of the 4-Methoxy-2, 3, 6-trimethylbenzenesulfonamide Protecting Group in the synthesis of macrocyclic polyamines. Bioconjugate Chem. 4:1993;236-245
28. McMurry T.J., Brechbiel M., Kumar K., Gansow O.A. Convenient Synthesis of Bifunctional Tetraaza Macrocycles. Bioconjugate Chem. 3:1992;108-117
29. Chong H.-S., Torti F.M., Torti S.V., Brechbiel M.W. Synthesis of 1, 3, 5-cis, cis-Triaminocyclohexane N-Pyridyl Derivatives as Potential Antitumor Agents. J Org Chem. 67:2002;8072-8078
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein Measurement With The Folin Phenol Reagent. J Biol Chem. 193:1951;265-275
31. Waterborg JH. The Lowry Method for Protein Quantitation. In: Walker JM, editor. Protein Protocols Handbook, 2nd Ed. Humana Press, Totowa, NJ 2002:7-10
32. Waterborg J.H., Matthews H.R. The Lowry Method for Protein Quantitation. Methods Mol Biol. 32:1994;1-4
33. Riddles P.W., Blakeley R.L., Zerner B. Ellman's reagent 5, 5′-dithiobis(2-nitrobenzoic acid) - a reexamination. Anal Biochem. 94:1979;75-81
34. Brinkley M. A Brief Survey of Methods for Preparing Protein Conjugates with Dyes, Haptens and Cross-Linking Reagents. Bioconjugate Chem. 3:1992;2-13
35. Jue R., Lambert J.M., Pierce L.R., Traut R.R. Addition of Sulfhydryl Groups to Escherichia coli Ribosomes by Protein Modification with 2-Iminothiolane (Methyl 4-Mercaptobutyrimidate). Biochemistry. 17:1978;5399-5406
36. Mandler R., Kobayashi H., Davis M.Y., Waldmann T.A., Brechbiel M.W. Modifications in Synthesis Strategy Improve the Yield and Efficacy of Geldanamycin-Herceptin Immunoconjugates. Bioconjugate Chem. 13:2002;786-791
37. Savvin S.B. Analytical Use of Arsenazo III. Determination of Thorium, Zirconium, Uranium and Rare Earth Elements. Talanta. 8:1961;673-685